title: The cost-effectiveness of duloxetine in chronic low back pain: a US private payer perspective.
authors: Gruenenthal GmbH - Market Access, Aachen, Germany.
authors: Hiltrud
authors: H
authors: Liedgens
authors: Rainer
authors: R
authors: Henske
mesh_terms: D000701:Analgesics, Opioid / Q000191:economics*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics*; D000927:Anticonvulsants / Q000191:economics*; D006801:Humans; D007348:Insurance, Health / Q000191:economics*; D017116:Low Back Pain / Q000191:economics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics*; D013876:Thiophenes / Q000191:economics*
chemical_list: D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes